The distribution of telomerase activity in patients with Helicobacter pylori positive gastritis

Aim: Helicobacter pylori is considered a class I carcinogen by the World Health Organization. We aimed to determine whether H. pylori has an effect on telomerase activity in patients with H. pylori related non-specific gastritis, atrophy, and intestinal metaplasia. Materials and methods: One hundred and seventy-two adult patients who underwent upper gastroduodenoscopy were enrolled in the study. Three biopsy specimens were taken from the antrum: 1 from the incisura angularis and 2 from the mid-antrum. Biopsy specimens taken from the incisura angularis were evaluated using the urease test for detection of H. pylori. The mid-antrum specimens were sent for histopathology and tissue telomerase activity testing. The histopathologic evaluation was performed based on the updated Sydney system. Quantitative detection of hTERT mRNA was performed with the available method for telomerase activity. Results: Of the 172 patients, 119 were eligible for the study. H. pylori was positive in 68 (57.14%) and negative in 51 (42.85%) of the cases (P > 0.05). Of the 119 patients, 6 had intestinal metaplasia, 27 had glandular atrophy, 62 had neutrophilic activation, and 102 had chronic inflammation. The telomerase activity of the H. pylori positive and negative groups did not show a statistically significant difference in patients with intestinal metaplasia, glandular atrophy, neutrophilic activation, and chronic inflammation (P > 0.05, for each). hTERT activity was higher in H. pylori positive patients who had glandular atrophy and intestinal metaplasia than the negative group. However, the differences were insignificant. Conclusion: We could not find any significant relationship between telomerase activity and H. pylori related non-specific gastritis, atrophy, and intestinal metaplasia. hTERT activity was higher in patients who had glandular atrophy and intestinal metaplasia (early stages of gastric carcinogenesis) in the H. pylori positive group. However, these differences were not significant. H. pylori, which is considered an oncogenic agent, may influence telomerase activity of further stages of carcinogenesis, particularly those after intestinal metaplasia.

[1]  Yan-Hong Gu,et al.  [Coordinated expression of c-Myc and telomerase activity in Helicobacter pylori infected gastric diseases]. , 2003, Zhonghua nei ke za zhi.

[2]  Hong Soo Kim,et al.  Helicobacter pylori and Telomerase Activity in Intestinal Metaplasia of the Stomach , 2002, The Korean journal of internal medicine.

[3]  L. Yin,et al.  The expression of hTERT mRNA and cellular immunity in gastric cancer and precancerosis. , 2002, World journal of gastroenterology.

[4]  D. Kobayashi,et al.  Helicobacter pylori Infection: Augmentation of Telomerase Activity in Cancer and Noncancerous Tissues , 2000, World Journal of Surgery.

[5]  A. Nakahara,et al.  Expression of human telomerase catalytic subunit gene in cancerous and precancerous gastric conditions , 2000, Journal of gastroenterology and hepatology.

[6]  K. Tsang,et al.  Helicobacter pylori and extra‐digestive diseases , 1999, Journal of gastroenterology and hepatology.

[7]  F. Cavalli,et al.  Molecular analysis of the progression from Helicobacter pylori-associated chronic gastritis to mucosa-associated lymphoid-tissue lymphoma of the stomach. , 1998, The New England journal of medicine.

[8]  B E Dunn,et al.  Helicobacter pylori , 1997, Clinical microbiology reviews.

[9]  D. Beall Classification and Grading of Gastritis: The Updated Sydney System , 1997 .

[10]  J. Shay,et al.  A survey of telomerase activity in human cancer. , 1997, European journal of cancer.

[11]  H. Yokozaki,et al.  Expression of Human Telomerase RNA Is an Early Event of Stomach Carcinogenesis , 1997, Japanese journal of cancer research : Gann.

[12]  M F Dixon,et al.  Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. , 1996, The American journal of surgical pathology.

[13]  E. Kuipers,et al.  Helicobacter pylori and gastric carcinogenesis. , 1996, Scandinavian journal of gastroenterology. Supplement.

[14]  J. Shay,et al.  Telomerase activity in human cancer. , 1996, Current opinion in oncology.

[15]  C B Harley,et al.  Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.

[16]  J. Crabtree,et al.  Gastric Interleukin‐8 and IgA IL‐8 Autoantibodies in Helicobacter pylori Infection , 1993, Scandinavian journal of immunology.

[17]  C B Harley,et al.  Telomere end-replication problem and cell aging. , 1992, Journal of molecular biology.

[18]  P. Correa,et al.  A human model of gastric carcinogenesis. , 1988, Cancer research.